Argus raised the firm’s price target on Philip Morris (PM) to $210 from $190 and keeps a Buy rating on the shares. The firm notes that given the prospects for higher revenue driven by its ZYN nicotine pouches, there is more runway for the stock, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PM:
- Philip Morris price target raised to $205 from $180 at Barclays
- American Express, T Mobile, Roblox, Philip Morris, Texas Instruments Insider Shake-Up
- Philip Morris Highlights Momentum in Smoke-Free Revenue Shift
- Philip Morris Reaffirms 2026 EPS Outlook and Growth
- Philip Morris backs FY26 adjusted EPS view $8.38-$8.53, consensus $8.40